AMANDA COLLIER: Open Payments
NPI 1477850915 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 49 payments from 16 companies in 2025. Trend: 2023 $818 · 2024 $875 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $234 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $110 |
| Janssen Biotech, Inc. | 3 | $80 |
| PFIZER INC. | 4 | $78 |
| GENZYME CORPORATION | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Celltrion USA Inc. | 3 | $57 |
| Ardelyx, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 1 | $21 |
Products named: XIFAXAN, DUPIXENT, LINZESS, RINVOQ, TREMFYA, VEGZELMA, ENTYVIO, IBSRELA.
Industry payments across NC — which companies pay providers there.
